GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 9,168.7 million compared to INR 9,341.1 million a year ago. Revenue was INR 9,388.4 million compared to INR 9,490.8 million a year ago. Net income was INR 1,934.2 million compared to INR 2,042.4 million a year ago. Basic earnings per share from continuing operations was INR 11.42 compared to INR 11.17 a year ago. Basic earnings per share was INR 11.42 compared to INR 12.06 a year ago.
For the six months, sales was INR 16,619.7 million compared to INR 16,524.8 million a year ago. Revenue was INR 17,115.5 million compared to INR 16,991.8 million a year ago. Net income was INR 3,127 million compared to INR 3,253.2 million a year ago. Basic earnings per share from continuing operations was INR 18.28 compared to INR 17.5 a year ago. Basic earnings per share was INR 18.46 compared to INR 19.2 a year ago.